Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction Journal Article


Authors: Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; Ma, W.; Torrisi, J. M.; Sonoda, Y.; Chi, D. S.; Lakhman, Y.; and Memorial Sloan Kettering Cancer Center Team Ovary
Contributors: Aherne, E. A.; Akin, O.; Broach, V.; Dickinson, S.; Gardner, G. J.; Grisham, R.; Hayes, S. A.; O’Cearbhaill, R.; Roche, K. L.; Paroder, V.; Petkovska, I.; Sarasohn, D. M.; Tew, W.; Vargas, H. A.; Ward, J.; Wibmer, A. G.; Woo, S.; Zivanovic, O.
Article Title: Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
Abstract: BACKGROUND. Imaging reports that consistently document all disease sites with a potential to increase surgical complexity or morbidity can facilitate ovarian cancer treatment planning. OBJECTIVE. The aims of this study were to compare simple structured reports and synoptic reports from pretreatment CT examinations in patients with advanced ovarian cancer in terms of completeness of documenting involvement of clinically relevant anatomic sites as well as to evaluate physician satisfaction with synoptic reports. METHODS. This retrospective study included 205 patients (median age, 65 years) who underwent contrast-enhanced abdominopelvic CT before primary treatment of advanced ovarian cancer from June 1, 2018, to January 31, 2022. A total of 128 reports generated on or before March 31, 2020, used a simple structured report (free text organized into sections); 77 reports generated on or after April 1, 2020, used a synoptic report (a list of 45 anatomic sites relevant to ovarian cancer management, each of which was classified in terms of disease absence versus presence). Reports were reviewed for completeness of documentation of involvement of the 45 sites. For patients who underwent neoadjuvant chemotherapy based on diagnostic laparoscopy findings or underwent primary debulking surgery with suboptimal resection, the EMR was reviewed to identify surgically established sites of disease that were unresectable or challenging to resect. Gynecologic oncology surgeons were electronically surveyed. RESULTS. The mean report turnaround time was 29.8 minutes for simple structured reports versus 54.5 minutes for synoptic reports (p < .001). A mean of 17.6 of 45 sites (range, four to 43 sites) were mentioned by simple structured reports versus 44.5 of 45 sites (range, 39–45) for synoptic reports (p < .001). Forty-three patients had surgically established unresectable or challenging-to-resect disease; involvement of anatomic site(s) with such disease was mentioned in 37% (11/30) of simple structured reports versus 100% (13/13) of synoptic reports (p < .001). All eight surveyed gynecologic oncology surgeons completed the survey. CONCLUSION. A synoptic report improved completeness of pretreatment CT reports in patients with advanced ovarian cancer, including for established sites of unresectable or challenging-to-resect disease. CLINICAL IMPACT. The findings indicate the role of disease-specific synoptic reports in facilitating referrer communication and potentially guiding clinical decision-making. © 2023 American Roentgen Ray Society. All rights reserved.
Keywords: aged; patient satisfaction; retrospective studies; ovarian cancer; ovarian neoplasms; tomography, x-ray computed; diagnostic imaging; retrospective study; genital neoplasms, female; physicians; ovary tumor; physician; satisfaction; ct; female genital tract tumor; personal satisfaction; documentation; humans; human; female; x-ray computed tomography; synoptic reporting; standardized lexicon; free-text reports
Journal Title: American Journal of Roentgenology
Volume: 221
Issue: 6
ISSN: 0361-803X
Publisher: American Roentgen Ray Society  
Date Published: 2023-12-01
Start Page: 760
End Page: 772
Language: English
DOI: 10.2214/ajr.23.29096
PUBMED: 37436033
PROVIDER: scopus
PMCID: PMC11348752
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Pamela Causa Andrieu -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ginger J Gardner
    273 Gardner
  2. Jean Marie Torrisi
    16 Torrisi
  3. Yuliya Lakhman
    100 Lakhman
  4. Junting Zheng
    201 Zheng
  5. Dennis S Chi
    712 Chi
  6. Yukio Sonoda
    475 Sonoda
  7. Oliver Zivanovic
    293 Zivanovic
  8. Weining Ma
    40 Ma
  9. Marinela Capanu
    390 Capanu
  10. Rachel Nicole Grisham
    175 Grisham
  11. Jae Nyung Ward
    19 Ward
  12. William P Tew
    247 Tew
  13. Oguz Akin
    272 Akin
  14. Sara Anne Hayes
    33 Hayes
  15. Andreas Georg Wibmer
    54 Wibmer
  16. Krishna   Juluru
    35 Juluru
  17. Vance Andrew Broach
    118 Broach
  18. Natalie Gangai
    61 Gangai
  19. Alanna Julianne Emily Aherne
    4 Aherne
  20. Viktoriya Paroder
    60 Paroder
  21. Sungmin Woo
    62 Woo
  22. Aaron M Praiss
    36 Praiss